Advisors Preferred’s Amedisys AMED Stock Holding History

Advisors Preferred’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-63,118	Closed	-$6.08M	–	237
2025 Q2	$6.08M	Buy	+63,118	New	+$5.97M	1%	25
2015 Q4	–	Sell	-388	Closed	-$15K	–	194
2015 Q3	$15K	Sell	388 -404	-51%	-$17K	0.02%	121
2015 Q2	$31K	Buy	+792	New	+$24.7K	0.02%	159
2015 Q1	–	Sell	-23,704	Closed	-$696K	–	255
2014 Q4	$696K	Buy	23,704 +22,108	+1,385%	+$546K	0.33%	76
2014 Q3	$32.2K	Buy	+1,596	New	+$30.8K	0.02%	151

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Advisors Preferred's AMED Position: Q3 2025 in Review

Advisors Preferred sold out of Amedisys (AMED) in Q3 2025, closing a stake of 63,118 shares — an estimated $6.08M sold.

Advisors Preferred first reported a position in AMED in Q3 2014 and held it in 5 quarters. The position peaked at $6.08M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Advisors Preferred reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Advisors Preferred sold 63,118 Amedisys shares in Q3 2025, an estimated $6.08M.
Advisors Preferred first reported a position in Amedisys in Q3 2014 and held it in 5 quarters.
Advisors Preferred's Amedisys position peaked at $6.08M in Q2 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Advisors Preferred's 13F filing for Q3 2025, filed 10 Nov 2025.